Minimally Invasive Surgery Safe for pT4 Colon Cancer Patients

Minimally invasive surgery (MIS) shows promise for pT4 colon cancer without compromising long-term oncologic outcomes.

In a study of 1,850 patients, those undergoing MIS had 2.4 times fewer major complications compared to open surgery.
After 42 months of follow-up, overall recurrence rates were similar for both groups, with better disease-free survival (DFS) and overall survival (OS) for the MIS group.

Well-selected patients—such as those with favorable clinical characteristics—can benefit from MIS, enhancing recovery with reduced complications.

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

Ann Surg Oncol2 Nov 2026

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

JAMA Surg30 Oct 2026

For severe slow-transit constipation, removing less colon gave similar symptom relief at one year, with less early incontinence.

Surg Endosc29 Oct 2026

In low rectal cancer surgery, removing the specimen through the anus was linked to fewer wound complications and less pain in the first two days.